NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $523 | -7.6% | 5,132 | -8.4% | 0.48% | +124.4% |
| Q2 2023 | $566 | -99.9% | 5,605 | -15.4% | 0.21% | +25.3% |
| Q4 2021 | $580,000 | -42.9% | 6,628 | -46.7% | 0.17% | -78.2% |
| Q3 2021 | $1,016,000 | -1.0% | 12,425 | +3.5% | 0.78% | +98.7% |
| Q1 2021 | $1,026,000 | -7.7% | 12,006 | +1.9% | 0.39% | -16.4% |
| Q4 2020 | $1,112,000 | +8.8% | 11,781 | +0.2% | 0.47% | -4.5% |
| Q3 2020 | $1,022,000 | -0.5% | 11,752 | -0.1% | 0.49% | -12.9% |
| Q2 2020 | $1,027,000 | +6.9% | 11,761 | +0.9% | 0.56% | -18.4% |
| Q1 2020 | $961,000 | +16.9% | 11,657 | +34.3% | 0.69% | +69.2% |
| Q4 2019 | $822,000 | +26.3% | 8,679 | +15.8% | 0.41% | +20.3% |
| Q3 2019 | $651,000 | +3.5% | 7,493 | +8.7% | 0.34% | -7.4% |
| Q2 2019 | $629,000 | -2.9% | 6,891 | +2.3% | 0.37% | +3.1% |
| Q1 2019 | $648,000 | +20.4% | 6,737 | +7.5% | 0.36% | -7.3% |
| Q4 2018 | $538,000 | – | 6,269 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |